Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
A compared with HBIO: revenue, margins and what each company keeps, and the suppliers and customers both name
A
Agilent Technologies, Inc.
Change
Mkt cap
Revenue
Revenue
HBIO
Harvard Bioscience Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
A
Agilent Technologies, Inc.
vs
HBIO
Harvard Bioscience Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
A
1 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±7.9%
▲
+1.68%
×0.22
Q2 FY26
±7.7%
▲
+16.87%
×2.19
Q1 FY26
±6.4%
▼
−3.01%
×0.47
Nov 25 '25
±6.5%
▲
+2.34%
×0.35
HBIO
1 of 4 reports
0 of 1
at or beyond implied
Report
implied
realized
× implied
Q2 FY26
±49.7%
▼
−4.07%
×0.08
= implied
A realized, solid
HBIO realized, hatched
One scale, both sides: full bar = 50%
× = |realized| ÷ implied
Source: market data
A
Agilent Technologies, Inc.
Change
174.77
▲
+1.74%
· post 175.00
Mkt cap
$49.3B
Revenue
$1.9B
Q3 FY26
Revenue
$6.9B
FY25
HBIO
Harvard Bioscience Inc
Change
8.38
▼
−0.95%
· post 8.38
Closed
Nov 6 '26
Mkt cap
$38.1M
Revenue
$23M
Q2 FY26
Revenue
$87M
FY25
vs
Compare
Closed
Nov 6 '26
A
Agilent Technologies, Inc.
vs
HBIO
Harvard Bioscience Inc
174.77
▲
+1.74%
post 175.00
Price
8.38
▼
−0.95%
post 8.38
$49.3B
Mkt cap
$38.1M
Q3 FY26
$1.9B
Revenue
$23M
Q2 FY26
FY25
$6.9B
Revenue
$87M
FY25
Change
Change
A
174.77
▲
+1.74%
vs
HBIO
8.38
▼
−0.95%
Closed
Nov 6 '26